Tesamorelin 10mg

Overview of Tesamorelin 10mg

Tesamorelin 10mg is a synthetic analog of growth hormone–releasing hormone (GHRH) engineered for laboratory research involving somatotropic axis regulation and receptor-mediated intracellular signaling pathways. As a modified GHRH analog, Tesamorelin is structurally designed to exhibit enhanced stability compared to endogenous GHRH in controlled experimental systems.

In laboratory environments, Tesamorelin 10mg is studied for its selective interaction with the growth hormone–releasing hormone receptor (GHRH-R) located on anterior pituitary somatotroph cells. This interaction provides a structured model for investigating intracellular second messenger cascades and transcriptional regulation associated with growth hormone synthesis pathways.

Supplied in lyophilized sterile powder form, Tesamorelin 10mg is intended strictly for laboratory research and analytical applications.

Molecular Characteristics

Tesamorelin is a stabilized GHRH analog composed of a modified peptide sequence designed to resist rapid enzymatic degradation in vitro. The structural optimization enhances stability and allows researchers to examine prolonged receptor interaction dynamics in controlled laboratory settings.

In experimental systems, Tesamorelin 10mg is referenced for research involving:

• GHRH receptor activation modeling

• cAMP-dependent intracellular signaling analysis

• Protein kinase A (PKA) pathway engagement

• Growth hormone gene transcription research

• Hypothalamic–pituitary axis feedback modeling

• Somatotropic pulsatility investigations

Its receptor selectivity makes Tesamorelin an important tool in comparative studies evaluating GHRH analogs versus growth hormone secretagogues (GHS).

Mechanism of Action (Research Context)

In controlled laboratory models, Tesamorelin binds to the GHRH receptor (GHRH-R), triggering activation of adenylate cyclase and increasing intracellular cyclic AMP (cAMP) levels.

This receptor activation may initiate:

• cAMP/PKA pathway signaling

• CREB-mediated transcriptional modulation

• Growth hormone gene transcription regulation

• Intracellular second messenger cascade activation

• Endocrine feedback loop modeling

Unlike ghrelin receptor agonists (GHS-R1a agonists), Tesamorelin acts specifically at the GHRH receptor, allowing researchers to isolate GHRH-mediated signaling pathways independent of ghrelin-associated mechanisms.

Laboratory investigations frequently compare Tesamorelin with compounds such as CJC-1295 (No DAC or with DAC) to evaluate differences in receptor pharmacodynamics and signal duration.

Research Applications

Tesamorelin 10mg is commonly referenced in laboratory investigations involving:

1. Hypothalamic–pituitary axis modeling

2. GHRH receptor pharmacology research

3. Somatotropic signaling pathway analysis

4. Intracellular cAMP cascade evaluation

5. Growth hormone pulsatility modeling

6. Endocrine transcription factor regulation studies

In molecular endocrinology laboratories, Tesamorelin serves as a structured model compound for examining peptide-mediated growth hormone pathway activation in vitro.

Researchers exploring endocrine signaling frequently consult peer-reviewed scientific databases such as the National Center for Biotechnology Information (NCBI) for foundational literature on GHRH analog research.

Stability and Laboratory Handling

Tesamorelin 10mg is supplied as a lyophilized sterile powder to maintain peptide stability and minimize hydrolytic degradation prior to reconstitution.

Laboratory handling recommendations include:

• Store under recommended refrigerated conditions

• Avoid repeated freeze–thaw cycles

• Reconstitute with sterile laboratory-grade solvent

• Follow institutional peptide handling protocols

Lyophilization supports long-term molecular stability and reproducibility across structured experimental applications.

Product Specifications

• Compound: Tesamorelin

• Classification: Growth hormone–releasing hormone (GHRH) analog

• Strength: 10mg

• Form: Lyophilized sterile powder

• Appearance: White to off-white solid

• Storage: Refrigerated conditions recommended

• Intended Use: Laboratory research only

Analytical Verification

Each batch of Tesamorelin 10mg undergoes analytical verification to confirm peptide identity and purity. Standard analytical procedures may include:

• High-performance liquid chromatography (HPLC)

• Mass spectrometry analysis

• Sequence validation

• Batch-to-batch consistency testing

Lot numbers are assigned to ensure traceability and support structured research documentation.

Broader Scientific Context

Tesamorelin 10mg is widely referenced in laboratory research exploring somatotropic axis regulation and receptor-mediated endocrine signaling pathways. As a stabilized GHRH analog, it provides researchers with a controlled framework for examining cAMP-dependent intracellular cascades and transcriptional regulation associated with growth hormone synthesis.

This compound contributes to broader understanding of peptide–receptor interaction dynamics within endocrine research models.

Compliance Notice

Tesamorelin 10mg is intended strictly for laboratory research use.

This product is not approved for human consumption, therapeutic application, or clinical use. It is sold exclusively for in vitro research, analytical testing, and scientific investigation by qualified professionals.